
LUF6000
CAS No. 890087-21-5
LUF6000( LUF-6000 | LUF 6000 )
Catalog No. M16423 CAS No. 890087-21-5
LUF6000 is a potent, selective, positive allosteric modulator (enhancer) of human A3 adenosine receptor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 294 | Get Quote |
![]() ![]() |
50MG | 897 | Get Quote |
![]() ![]() |
100MG | 1575 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLUF6000
-
NoteResearch use only, not for human use.
-
Brief DescriptionLUF6000 is a potent, selective, positive allosteric modulator (enhancer) of human A3 adenosine receptor.
-
DescriptionLUF6000 is a potent, selective, positive allosteric modulator (enhancer) of human A3 adenosine receptor, enhance Emax but without affecting agonist potency; enhance sagonist efficacy in a functional assay by 45% and decreases dissociation rate similarly without influencing agonist potency, LUF6000 is superior to that of DU124183.
-
In VitroModulatory effect of 10 μM LUF6000 on Cl-IB-MECA-induced [35S]GTPγS binding in assays with HEK 293 cell membranes expressing human, dog, rabbit, or mouse A3 adenosine receptors with EC50 ranging from 39 to 172 nM.
-
In VivoLUF6000 induces anti-inflammatory effect in 3 experimental animal models of rat adjuvant induced arthritis, monoiodoacetate induced osteoarthritis, and concanavalin A induced liver inflammation in mice.
-
SynonymsLUF-6000 | LUF 6000
-
PathwayApoptosis
-
TargetAdenosine Receptor
-
RecptorAdenosine Receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number890087-21-5
-
Formula Weight411.327
-
Molecular FormulaC22H20Cl2N4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESClC1=CC=C(NC2=NC3=CC=CC=C3C4=C2NC(C5CCCCC5)=N4)C=C1Cl
-
Chemical Name3H-Imidazo[4,5-c]quinolin-4-amine, 2-cyclohexyl-N-(3,4-dichlorophenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. G?bly?s A, et al. J Med Chem. 2006 Jun 1;49(11):3354-61.
2. Gao ZG, et al. BMC Pharmacol. 2008 Dec 12;8:20.
3. Gao ZG, et al. Biochem Pharmacol. 2011 Sep 15;82(6):658-68.
molnova catalog



related products
-
KI-7
KI-7 is an adenosine A2B receptor positive allosteric modulator.
-
MSX-3 hydrate
MSX-3 hydrate is a potent, specific adenosine A2A receptor (A2AR) antagonist.
-
Labetalol
Labetalol is a mixed alpha/beta-adrenergic antagonist.It is used to treat high blood pressure. It can be given by mouth for long term hypertension management or intravenously in severe hypertensive situations. The pharmacokinetics of labetalol is affected by the common CYP2C19 polymorphisms.